Humacyte, Inc. Warrant (HUMAW) Stock Price
HUMAWStock
$0.00
Market Cap—
P/E—
PEG Ratio—
Div yield—
Beta2.62
HUMAW Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-108.08%
Price vs S&P 500 (4W)-57.50%
VGM Score1.53
Industry Peers — Biological Products(183)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
HUMAWHumacyte, Inc. Warrant | — | — | F | $0.00 |
| AMGNAmgen Inc | C | C | B | $442.24 |
| GILDGilead Sciences Inc | C | B | B | $148.77 |
| MRNAModerna, Inc. Common Stock | D | C | A | $158.83 |
| ARGXargenx SE American Depositary Shares | D | A | B | $1019.49 |
| RVMDRevolution Medicines, Inc. Common Stock | F | — | A | $211.38 |
| BIIBBiogen Inc. Common Stock | C | D | B | $220.77 |
| BNTXBioNTech SE American Depositary Share | C | C | B | $114.05 |
| NBIXNeurocrine Biosciences Inc | C | B | C | $153.37 |
| EXELExelixis Inc | C | B | B | $56.72 |
| HALOHalozyme Therapeutics, Inc. | C | B | A | $109.32 |
About Humacyte, Inc. Warrant
Humacyte develops acellular bioengineered tissues for regenerative medicine, focusing on vascular grafts and engineered organs for vascular trauma, peripheral arterial disease, and dialysis access. The company's pipeline includes tissue-engineered vessels and advanced organ systems designed to address significant patient needs across multiple therapeutic areas.